valproate sodium

DRUG5 trials

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS), Sanofi, Sun Yat-sen University, Universidad Autonoma de San Luis Potosí, University of North Carolina, Chapel Hill

Conditions

Adverse EffectsBipolar DisorderBrain HypoxiaBrain Injuries, AcuteBrain Injuries, TraumaticBrain IschemiaComaEpilepsy

Phase 3

Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures

CompletedNCT00004817

National Institute of Neurological Disorders and Stroke (NINDS)Head Injuries, Post-Traumatic Seizure Disorder

Start: 1991-02-28Target: 385Updated: 2005-06-24

Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.

CompletedNCT04698525

Universidad Autonoma de San Luis PotosíMigraine Headache

Start: 2019-02-15End: 2020-01-15Updated: 2024-05-09

Phase 4

VALID : VAlproate Versus LIthium in Bipolar Disorders

CompletedNCT00264173

SanofiBipolar Disorder

Start: 2004-02-29End: 2006-09-30Target: 270Updated: 2007-11-16

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

TerminatedNCT06081283

University of North Carolina, Chapel HillBrain Hypoxia, Brain Injuries, Acute, Brain Injuries, Traumatic +7

Start: 2023-11-20End: 2025-01-22Updated: 2025-11-14

Unknown Phase

Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment

Sun Yat-sen UniversityAdverse Effects, Epilepsy

Start: 2010-08-31End: 2013-07-31Target: 150Updated: 2010-07-30